Corrections

The next step in controlling HBV in China

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4819 (Published 30 July 2013) Cite this as: BMJ 2013;347:f4819

In this Editorial by Yuanyong Xu and colleagues (BMJ 2013;347:f4503, doi:10.1136/bmj.f4503), the abbreviation HPV, rather than HBV, was mistakenly used in two instances. The first line of the second paragraph should have read: “The Chinese government introduced infant vaccination with HBV vaccine in 1992 . . .” and the first line of the sixth paragraph should have read: “The antiviral agent lamivudine seems to be safe when given during the last weeks of pregnancy to women with chronic HBV infection.”

Notes

Cite this as: BMJ 2013;347:f4819

View Abstract